Dec 14, 2023, 15:41
Samer Al Hadidi: Will use of CAR-T earlier be better?
Samer Al Hadidi, Assistant Professor at UAMS Myeloma Center, made the following post on X/Twitter:
“ASH23 multiple myeloma
KarMMa-3 updated analysis:
Despite improved PFS with earlier use of Ide-Cel, OS was not different Unfortunate we don’t have a tail for PFS with Ide-cel and unfortunate that OS is not better (per ITT, many pts died before product).
Will use of CAR-T earlier be better?“
Source: Samer Al Hadidi/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 2, 2024, 10:01
Dec 2, 2024, 09:04
Dec 1, 2024, 22:10